-
Stocks diverge with earnings, tech in focus
-
North Korea fires ballistic missile: South Korea military
-
England recall batsman Lawrence for Pakistan series
-
'Don't have to hide': Thai IDs, legal work give hope to Myanmar refugees
-
Siemens shares plunge on disappointing guidance raise
-
Stocks mixed with tech firms back under pressure
-
New Australia coach Kiss gives Japan starts to Ross, Amatosero
-
How Blundell's old school tactic ended England's 'Bazball' era
-
'Stretch our money': Romanians face highest EU inflation
-
Israel reports troop deaths as Lebanon talks underway in Rome
-
Iran says close to Hormuz plan with Oman, but reopening depends on US
-
Seeds Rybakina, Pegula, Gauff reach third round at WTA Toronto
-
Messi scores twice to set Leagues Cup record in Miami victory
-
Police raid South Korea FA in probe into World Cup coach appointment
-
Asian stocks mostly down with tech firms back under pressure
-
Low water on Germany's Rhine river threatens new blow to economy
-
Back to the future as world champion Springboks host All Blacks
-
Ex-Wallabies Foley, Phipps rejoin Waratahs ahead of home World Cup
-
India youth protests highlight mistrust in 'lapdog' media
-
Rising Kenyan lakes push crocodiles closer to homes
-
Pacific islands alarmed by Trump-backed push for deep-sea mining
-
Istanbul cymbals: From Ottoman war tool to pulse of global music
-
Erratic rains dictate menu at three-star Michelin restaurant in Brazil
-
Myanmar ex-junta chief on first Thailand trip as civilian leader
-
Zverev, Auger-Aliassime and Medvedev exit Montreal Masters
-
Environmental disaster looms as tanker leaks off Oman
-
Google-parent Alphabet shakes up AI division
-
Embattled Infantino sees minnows Malawi reach WAFCON quarter-finals
-
FIFA back Infantino, apologise for World Cup privatisation plan
-
Seeds Rybakina, Pegula and Gauff advance at WTA Toronto event
-
Auger-Aliassime out of Montreal ATP event with injury
-
Zverev, Auger-Aliassime exit star-short Montreal Masters
-
Colombian baby hippo of Escobar stock dies after rescue
-
Embattled FIFA chief Infantino in emergency talks in Morocco
-
Preakness shifts 2027 dates to entice more Derby horses
-
Castaway SpaceX rocket stage crashed into Moon, scientists say
-
Guatemalan volcano eruption ends, locals return home
-
Dow edges to record as markets parse prospects for Hormuz deal
-
WHO chief urges stronger Ebola response in DR Congo visit
-
Salah arrives in Turkey to complete Trabzonspor move
-
Newcastle appoint Jaissle as new head coach after Howe exit
-
AFP journalist to be honored at International Press Freedom Awards
-
Swiss ski star Lara Gut-Behrami calls time on 18-year career
-
Turkish MPs back limited amnesty for Kurdish militants
-
US indicts leaders of Mexico's CJNG cartel, ups reward money
-
Noosha Aubel: Czy poradzi sobie z problemami Poczdamu?
-
Noosha Aubel: Klarar hon av Potsdams problem?
-
Noosha Aubel: Είναι σε θέση να αντιμετωπίσει τα προβλήματα του Πότσδαμ;
-
Noosha Aubel: Zvládne problémy Postupimi?
-
نوشا أوبيل: هل هي على مستوى التحديات التي تواجهها بوتسدام؟
US to reclassify cannabis as low-risk drug, in major shift
US President Joe Biden's administration is set to reclassify marijuana as a less dangerous drug, a source said Tuesday -- a historic shift that would bring federal policy more in line with public opinion.
The US Department of Justice was expected to send a recommendation to the White House on Tuesday to "reschedule marijuana," the source told AFP on condition of anonymity.
It comes after Joe Biden became the first president to initiate a federal review into the matter in 2022.
The issue is seen as a potential vote winner for Biden as he faces Republican Donald Trump in a tough election rematch this November, especially among younger people whom the Democratic incumbent is struggling to court.
Marijuana has been classified since 1970 as a so-called "Schedule I" drug along with heroin, ecstasy and LSD, meaning it is deemed to have no accepted medical use and a high potential for abuse.
But it would be downgraded to a Schedule III drug under the proposal, along with drugs like ketamine and painkillers containing codeine, with a moderate to low likelihood of dependence, the source said.
"This is the next step in the formal rescheduling process," the source said. The process would still require a long period for public comments and finalization.
Commenting on the impending move, Paul Armentano, deputy direction of the advocacy group NORML, said: "It is significant for these federal agencies, and the DEA and FDA in particular, to acknowledge publicly for the first time what many patients and advocates have known for decades: that cannabis is a safe and effective therapeutic agent for tens of millions of Americans."
But he added that reclassifying the substance did not go far enough and it should be removed from the Controlled Substances Act altogether, which would require legislation.
A Pew Research Center survey last month found 88 percent of Americans said marijuana should be legal for medical or recreational use. Just 11 percent said it should not be legal at all.
- Multibillion dollar business -
Cannabis was first outlawed at the federal level in 1937, a decision that critics say was made largely along racist reasoning, as the drug was perceived as being intimately tied to jazz music and to Mexican immigrants.
The 1970s brought the "War on Drugs," which likewise disproportionately hit minorities -- before the medical marijuana movement took root in the 1990s, and in 2012, US states began to make recreational cannabis legal for adults.
Cannabis is today a multi-billion-dollar business in the United States, with more than half of all states having legalized recreational and medicinal cannabis use, including California and New York.
But since the drug remains a controlled substance at the national level, everyone involved is still technically breaking the law of the land.
The ban makes it difficult for businesses to access banking services, stops federal funding for medical marijuana research and prevents interstate commerce, as well as federal regulation on best practices and protocols for marijuana.
After Canada fully legalized cannabis in 2018, US Customs and Border Patrol officers began issuing lifetime entry bans to Canadians who answered "yes" when asked at checkpoints if they had ever consumed the drug.
The same agency warned residents in New Mexico that it would continue to prosecute offenders caught with the substance at highway checkpoints, even after the state had legalized it.
Native American lands also experience raids carried out by the federal Bureau of Indian Affairs, despite the fact they live on nominally self-governing territories.
Cannabis advocates warn that without legislation, a future presidential administration unsympathetic to legalization could go after businesses and consumers even in states where the plant is legal.
Former president Trump's first attorney general Jeff Sessions threatened to do this, but federal prosecutors ultimately decided it was a waste of their time.
P.Mira--PC